Is Low Cholesterol Dangerous?December 2004
|LE Magazine December 2004|
|Is Low Cholesterol Dangerous? |
By Sergey A. Dzugan
After reviewing the medical literature on the link between hypocholesterolemia and various pathologies, we suspected that this patient’s problem was insufficient hormone production. Lack of cholesterol for steroidogenesis can be a causal factor for the multiple disorders mentioned previously. One study showed impaired reproductive efficiency in hypo-cholesterolemia induced animals.10 In this case report, we can hypothesize that hypocholesterolemia played a crucial role in the patient’s deficient production of steroid hormones, and that her multiple symptoms were related to those deficiencies. From our point of view, any program that does not restore “foundational chemicals” (such as steroid hormones) is doomed to failure. This is because metabolism will continue to be slow, intestinal absorption will be poor, the immune system will be defective, and the neurohormonal system will be imbalanced. This is why we always stress the importance and necessity of the first step of any program: restoration of optimal levels of steroid hormones.
Cholesterol is especially abundant in the nervous system and plays an important role in cellular structure and function. Changes in serum levels may affect neurotransmission in the central nervous system. Substantial evidence suggests that serum cholesterol levels may be associated with variations in mental state or personality.11 Imbalanced blood chemistry and lipid metabolism can usually influence depressive states. It is known that neurosteroids such as DHEA may antagonize cortisol activity and have mood-elevating effects of their own.12 A low DHEA level can be an indicator of diminished capacity to protect against stress.
Intensive pharmacological studies suggest that neurosteroids may be involved in learning and memory processes.13 Patients with fatigue may experience significant impairments in learning and memory,14 and can suffer from major depression, anxiety, and panic disorder.15 Treatment for chronic fatigue is usually symptom based and includes pharmacological and behavioral strategies.16 Our findings suggest that physiological and psychological factors work together. Restoring normal physiology is central to correcting disorders such as those described in this case report.
Obesity’s causes are poorly understood, and both the prevention and treatment of obesity are difficult.17 In this case, a weight-loss program was initiated only after a significant improvement in quality of life. It is known that:
• HCA may be helpful in weight loss because of its effects on metabolism.18
• CLA can reduce fat deposi- tion and increase lipolysis in adipocytes, possibly with enhanced fatty-acid oxidation in both muscle cells and adipocytes.19
Hypocholesterolemia is usually associated with reduced antioxidant reserves and absolute vitamin E levels.20 This is why our program incorporated antioxidants.
Exercise was also an important part of our program, as physical activity can enhance the synthesis and release of cholesterol in the liver.21 This is very important because an enhanced cholesterol level can be expected to increase hormonal production, thus reducing the amount of hormones to be replaced.
This case study describes a patient who had low level of steroid hormones related to low cholesterol, with multiple symptoms typical of hormonal deficiencies. Multimodal approaches using hormones, nutritional supplements, exercise, and lifestyle modifications can help control most problems related to low cholesterol. Hypocholesterolemia can be a potential warning sign of concurrent diseases or a signal of rapidly declining health.
Sergey A. Dzugan, MD, PhD, was formerly chief of cardiovascular surgery at the Donetsk Regional Medical Center in Donetsk, Ukraine. Dr. Dzugan’s current primary interests are anti-aging, biological therapy for cancer, cholesterol, and hormonal disorders.
1. Zureik M, Courbon D, Ducimetiere P. Decline in serum total cholesterol and the risk of death from cancer. Epidemiology. 1997 Mar;8(2):137-43.
2. Neaton JD, Blackburn H, Jacobs D, et al. Serum cholesterol level and mortality find- ings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med. 1992 Jul;152(7):1490-500.
3. Sarchiapone M, Roy A, Camardese G, De Risio S. Further evidence for low serum cholesterol and suicidal behaviour. J Affect Disord. 2000 Dec;61(1-2):69-71.
4. Glueck CJ, Tieger M, Kunkel R, Hamer T, Tracy T, Speirs J. Hypocholesterolemia and affective disorders. Am J Med Sci. 1994 Oct;308(4):218-25.
5. Iribarren C, Reed DM, Burchfiel CM, Dwyer JH. Serum total cholesterol and mortality. Confounding factors and risk modifications in Japanese-American men. JAMA. 1995 Jun 28;273(24):1926-32.
6. Oganov RG, Sestov DB, Deev AD, et al. Increased risk of death from coronary heart disease in men with low blood con- centration of total cholesterol and low den- sity lipoprotein cholesterol according to data from a prospective epidemiologic study in Moscow and Leningrad within the framework of Soviet-American coopera- tion. Ter Arkh. 1991;63(1):6-11.
7. Corti MC, Guralnik JM, Salive ME, et al. Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med. 1997 May 15;126(10):753-60.
8. Dzugan SA, Smith RA. Broad spectrum restoration in natural steroid hormones as possible treatment for hypercholes- terolemia. Bull Urg Rec Med. 2002;3:278- 84.
9. Dzugan SA, Smith RA. Hypercholesterol- emia treatment: a new hypothesis or just an accident. Med Hypotheses. 2002 Dec;59(6):751-6.
10. Shambharkar AV, Varshney VP, Agarwal N, Agarwal SK, Sanwal PC, Pande JK. Changes in serum triiodothyronine, thy- roxine, estradiol-17 beta, progesterone lev- els and egg production in hypocholes- terolemia induced Japanese quails Coturnix coturnix japonica. Indian J Exp Biol. 1996 Oct;34(10):987-90.
11. Boston PF, Dursun SM, Reveley MA. Cholesterol and mental disorder. Br J Psychiatry. 1996 Dec;169(6):682-9.
12. Heinz A, Weingartner H, George D, Hommer D, Wolkowitz OM, Linnoila M. Severity of depression in abstinent alco- holics is associated is associated with monoamine metabolites and dehy- droepiandrosterone-sulfate concentra- tions. Psychiatry Res. 1999 Dec 20;89(2):97- 106.
13. Vallee M, Mayo W, Le Moal M. Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive aging. Brain Res Brain Res Rev. 2001 Nov;37(1-3):301-12.
14. Marcel B, Komaroff AL, Fagioli LR, Kornish RJ, Albert MS. Cognitive deficits in patients with chronic fatigue syndrome. Biol Psyciatry. 1996 Sep 15;40(6):535-41.
15. Manu P, Lane TJ, Matthews DA. Chronic fatigue and chronic fatigue syndrome: clin- ical epidemiology and aetiological classifi- cation. Ciba Found Symp. 1993;173:23-31.
16. Afari N, Buchwald D. Chronic fatigue syn- drome: a review. Am J Psychiatry. 2003 Feb;160(2):221-36.
17. Ogden CL, Carroll MD, Flegal KM. Epidemiologic trends in overweight and obesity. Endocrinol Metab Clin North Am. 2003 Dec;32(4):741-60.
18. Thom E. Hydroxycitrate (HCA) in the treatment of obesity. Int J Obes Relat Metab Disord. 1996;20(Suppl 4):75.
19. Park Y, Albright KJ, Liu W, Storkson JM, Cook ME, Pariza MW. Effect of conjugated linoleic acid on body composition in mice. Lipids. 1997 Aug;32(8):853-8.
20. Muldoon MF, Kritchevsky SB, Evans RW, Kagan VE. Serum total antioxidant activi- ty in relative hypo- and hypercholes- terolemia. Free Radic Res. 1996 Sep;25(3):239-45.
21. Abe T, Sakamoto T, Higashi T, Hirota K. Effects of exercise on hypocholesterolemia of stroke-prone spontaneously hyperten- sive rats. Atherosclerosis. 1989 Oct;79(2- 3):113-9.